French M T, Martin R F
University of Miami, Health Services Research Center, Miami 33136, USA.
J Subst Abuse Treat. 1996 Nov-Dec;13(6):453-66. doi: 10.1016/s0740-5472(96)00128-6.
The purpose of this article is to provide researchers, clinicians, and policymakers with a common source of published cost estimates for drug abuse consequences. Across the broad range of potential complications associated with drug abuse, some of the cost elements are specific and directly related to drug abuse per se (e.g., drug treatment costs), while other items may be related to drug abuse (e.g., typical emergency room cost). The results presented here are based on a review of completed and ongoing studies, which include published papers, monographs, conference presentations, working papers, reports, insurance company records, newsletters, and expert judgment. Whenever possible, we report an average cost estimate and the range of available estimates. Each cost element is normalized to 1994 dollars. The results are organized by type of cost and are presented in tabular format so that the findings can be easily understood and used.
本文的目的是为研究人员、临床医生和政策制定者提供已发表的药物滥用后果成本估算的共同来源。在与药物滥用相关的广泛潜在并发症中，一些成本要素是特定的且与药物滥用本身直接相关（例如，药物治疗成本），而其他项目可能与药物滥用有关（例如，典型的急诊室成本）。这里呈现的结果基于对已完成和正在进行的研究的综述，这些研究包括已发表的论文、专著、会议报告、工作论文、报告、保险公司记录、时事通讯和专家判断。只要有可能，我们就报告平均成本估算和可用估算的范围。每个成本要素都按1994年美元进行了标准化。结果按成本类型进行组织，并以表格形式呈现，以便研究结果能够易于理解和使用。
